Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Haojun Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9101-8884; OpenAlex author ID A5031029049. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Prognostic value of multiparameter [68Ga]Ga-DOTA-FAPI-04 PET/MR imaging biomarkers for patients with advanced pancreatic cancer. Co-author DOI 10.1007/s00259-025-07491-w↗
  2. Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. Last author DOI 10.1016/j.cpet.2023.02.001↗
  3. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients wi… Last author DOI 10.1007/s00259-021-05576-w↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yizhen Pang · 2 shared papers, 2022–2023 · strength 0.35
  2. Liang Zhao · 2 shared papers, 2022–2023 · strength 0.35
  3. Changjing Zuo · 1 shared paper, 2026 · strength 0.26
  4. Chao Cheng · 1 shared paper, 2026 · strength 0.26
  5. Zeyu Zhang · 1 shared paper, 2026 · strength 0.26
  6. Shiwei Guo · 1 shared paper, 2026 · strength 0.26
  7. Gang Jin · 1 shared paper, 2026 · strength 0.26
  8. Weiwei Su · 1 shared paper, 2026 · strength 0.26
  9. Yu-Chao Li · 1 shared paper, 2026 · strength 0.26
  10. Shuangjia Wang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.